Medtech Is Facing Stormy Season for Venture Capital

BOSTON – With today’s economy it’s hard to accurately diagnose the state of financings in the medtech and diagnostics industry.

A study by Deloitte says that while overall venture financing in medtech increased 67% since 2017, medtech investors are still shying away from unproven early-stage technologies, focusing instead on late-stage diagnostic and digital companies.